Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by ImmunohistochemistryKi Y. Chung, Leonard B. Saltz, Jinru Shia et al.|Journal of Clinical Oncology|2005Cited by 1.1k
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapyJordi Barretina, Samuel Singer, Barry S. Taylor et al.|Nature Genetics|2010Cited by 725
Phase II Study of Sorafenib in Patients With Metastatic or Recurrent SarcomasRobert G. Maki, Gary K. Schwartz|Journal of Clinical Oncology|2009Cited by 573
Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal MelanomaRichard D. Carvajal, Gary K. Schwartz, Jeffrey A. Sosman et al.|JAMA|2014Cited by 429
Single‐institution experience with ipilimumab in advanced melanoma patients in the compassionate use settingGeoffrey Y. Ku, Jedd D. Wolchok, Jianda Yuan et al.|Cancer|2010Cited by 422